<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00914069</url>
  </required_header>
  <id_info>
    <org_study_id>62009123</org_study_id>
    <nct_id>NCT00914069</nct_id>
  </id_info>
  <brief_title>Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter</brief_title>
  <official_title>Evaluation of the Safety and Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter for Peripheral Intravenous (PIV) Insertion in Children, Oncology Patients and Elderly: a Controlled Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C. R. Bard</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>C. R. Bard</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will test a hypothesis that the RIVS system will have a higher rate of successful
      first PIV placement compared to conventional catheter without a significant increase in
      complications and time of procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis to be statistically tested was that the RIVS system will have a higher rate of
      successful first attempt peripheral intravenous placement success as compared to conventional
      peripheral intravenous catheters without a significant increase in device related
      complications and procedure time.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Funding Stopped
  </why_stopped>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt</measure>
    <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
    <description>A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Summary of Major Complications</measure>
    <time_frame>Post-PIV placement until catheter removal (usually within 4 days)</time_frame>
    <description>Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time Required to Obtain Access</measure>
    <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
    <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second Stick Success Rate</measure>
    <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
    <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of Minor Complications</measure>
    <time_frame>Post-PIV placement until catheter removal (usually within 4 days)</time_frame>
    <description>Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">175</enrollment>
  <condition>Vascular Access Complication</condition>
  <arm_group>
    <arm_group_label>RIVS vascular access</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RIVS vascular access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional vascular access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional vascular access</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RIVS vascular access</intervention_name>
    <description>Access to peripheral vasculature</description>
    <arm_group_label>RIVS vascular access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional vascular access</intervention_name>
    <description>Vascular access using conventional venous access device</description>
    <arm_group_label>Conventional vascular access</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Any type of oncology patients undergoing chemotherapy or post-chemotherapy (without a
             port/cannula), or over 65 years

          -  Requires peripheral IV as determined by examining physician

          -  Requires the IV when a study nurse or resident is available

          -  Able to sign an informed consent

        Exclusion Criteria

          -  Active systemic or cutaneous infection or inflammation;

          -  Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids;

          -  Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's
             disease or current platelet count &lt; 100,000 cells/mm3, baseline International
             Normalized Ratio (INR) â‰¥1.8, or fibrinogen level less than 150 mg/dl (if received a
             fibrinolytic agent within prior 24 hours);

          -  Currently involved in any other investigational clinical trials;

          -  Previous vascular grafts or surgery at the target vessel access site;

          -  Females who are pregnant, planning to become pregnant within 3 months of the
             procedure, or lactating;

          -  Central line available

          -  Requirement for immediate IV placement (patient's condition would potentially be
             compromised if there is a time delay in IV placement)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey S Stuart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Outpatient Surgery Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington Outpatient Surgery Center</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2009</study_first_submitted>
  <study_first_submitted_qc>June 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2009</study_first_posted>
  <results_first_submitted>November 14, 2016</results_first_submitted>
  <results_first_submitted_qc>March 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 13, 2017</results_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Prior to assignment to groups, two subjects withdrew from the study. Also prior to group assignment, one subject did not have a consent form and was excluded from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RIVS Vascular Access</title>
          <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
        </group>
        <group group_id="P2">
          <title>Conventional Vascular Access</title>
          <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>RIVS Vascular Access</title>
          <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
        </group>
        <group group_id="B2">
          <title>Conventional Vascular Access</title>
          <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="84"/>
            <count group_id="B2" value="88"/>
            <count group_id="B3" value="172"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.1" spread="9.4"/>
                    <measurement group_id="B2" value="67.2" spread="10.9"/>
                    <measurement group_id="B3" value="66.7" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Sex data were missing for two (2) subjects.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="86"/>
                    <count group_id="B3" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="84"/>
                    <count group_id="B2" value="88"/>
                    <count group_id="B3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt</title>
        <description>A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.</description>
        <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIVS Vascular Access</title>
            <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
          </group>
          <group group_id="O2">
            <title>Conventional Vascular Access</title>
            <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
          </group>
        </group_list>
        <measure>
          <title>IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt</title>
          <description>A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>Threshold for significance was p less than or equal to 0.05 by a one-tailed Fisher Exact Test.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Summary of Major Complications</title>
        <description>Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.</description>
        <time_frame>Post-PIV placement until catheter removal (usually within 4 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIVS Vascular Access</title>
            <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
          </group>
          <group group_id="O2">
            <title>Conventional Vascular Access</title>
            <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
          </group>
        </group_list>
        <measure>
          <title>Summary of Major Complications</title>
          <description>Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Required to Obtain Access</title>
        <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
        <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIVS Vascular Access</title>
            <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
          </group>
          <group group_id="O2">
            <title>Conventional Vascular Access</title>
            <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
          </group>
        </group_list>
        <measure>
          <title>Time Required to Obtain Access</title>
          <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="4.0"/>
                    <measurement group_id="O2" value="5.0" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Second Stick Success Rate</title>
        <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
        <time_frame>An access attempt usually ranges from 0 to 45 minutes in duration.</time_frame>
        <population>Number of Participants Analyzed is not consistent with numbers provided in the Participant Flow Module because not all participants required a second attempt at catheter placement.</population>
        <group_list>
          <group group_id="O1">
            <title>RIVS Vascular Access</title>
            <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
          </group>
          <group group_id="O2">
            <title>Conventional Vascular Access</title>
            <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
          </group>
        </group_list>
        <measure>
          <title>Second Stick Success Rate</title>
          <description>A secured flushed IV will be indicative of a successful PIV placement.</description>
          <population>Number of Participants Analyzed is not consistent with numbers provided in the Participant Flow Module because not all participants required a second attempt at catheter placement.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summary of Minor Complications</title>
        <description>Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.</description>
        <time_frame>Post-PIV placement until catheter removal (usually within 4 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIVS Vascular Access</title>
            <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
          </group>
          <group group_id="O2">
            <title>Conventional Vascular Access</title>
            <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
          </group>
        </group_list>
        <measure>
          <title>Summary of Minor Complications</title>
          <description>Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>RIVS Vascular Access</title>
          <description>RIVS vascular access
RIVS vascular access: Access to peripheral vasculature</description>
        </group>
        <group group_id="E2">
          <title>Conventional Vascular Access</title>
          <description>Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="88"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="88"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Minor Vasular Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="88"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Principal Investigators may publish or present the study results with prior consent of the Sponsor, but will not disclose confidential information. Prior to submission by a Principal Investigator for publication or presentation, the Sponsor will be provided with the opportunity to review the submission for confidential information and accuracy.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gina Gilbert</name_or_title>
      <organization>Bard Access Systems, Inc.</organization>
      <phone>407-489-0835</phone>
      <email>Gina.Gilbert@crbard.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

